<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364815">
  <stage>Registered</stage>
  <submitdate>22/08/2013</submitdate>
  <approvaldate>28/08/2013</approvaldate>
  <actrnumber>ACTRN12613000957796</actrnumber>
  <trial_identification>
    <studytitle>The effect of different media for sperm handling and injection at intracytoplasmic sperm injection (ICSI) on subsequent embryo cleavage: a comparison of the use of polyvinylpyrrolidone (PVP) and hyaluronan.</studytitle>
    <scientifictitle>Morphokinetic comparisons of embryos derived from intracytoplasmic sperm injection (ICSI) procedures involving polyvinylpyrrolidone (PVP) or hyaluronan as sperm handling reagent - a randomized sibling oocyte study </scientifictitle>
    <utrn>U1111-1147-0159</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Infertility</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fertility including in vitro fertilisation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Sibling oocytes collected from each participating patient will be randomly allocated into the polyvinylpyrrolidone (PVP) (control) and hyaluronan (HA) (treatment) groups. Oocytes will undergo intracytoplasmic sperm injection (ICSI) with different handling medium in each group accordingly. Subsequent embryo culture condition is identical for both groups.</interventions>
    <comparator>This is an auto-controlled sibling oocyte study. One of the 2 equally divided groups will work as the control (PVP) while the other group as treatment group (HA).</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Fertilisation rate(%), 
= (number of oocyte normally fertilised)/(number of oocyte inseminated)x100%

</outcome>
      <timepoint>24 hrs</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Time post ICSI insemination to reach syngamy, 2,3,4,5,6,7,8-cell stages (t2,t3,t4,t5,t6,t7,t8)(hours)
 
Embryoscope is a time-lapse photographing incubator providing accurate timings for biological events during embryo development. Timings for syngamy and t2,t3,t4,t5,t6,t7,t8 of embryos cultured in the Embryoscope will be automatically recorded .  


</outcome>
      <timepoint>72 hrs</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Synchronity of cleavage: s2 and s3 (hours)

S2=t4-t3 (t3 &amp; t4 are available from primary outcome 2)
S3=t8-t5 (t5 &amp; t8 are available from primary outcome 2)
</outcome>
      <timepoint>72 hrs</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Embryo implantation rate (%) after transfer

Implantation is confirmed by detection of fetal heart beat under ultrasound 5 weeks after oocyte pick-up.

Implantation rate (%) = (number of fetal heart beat detected)/(number of embryo transferred) x 100%</outcome>
      <timepoint>5 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients having ICSI treatment criteria at Fertility North. Indications for ICSI include low sperm count, low sperm motility, poor sperm morphology or poor fertilisation in previous conventional insemination.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients requiring sperm selection using PICSI dishes, eg male partner with increased incidence of sperm DNA fragmentation.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/11/2013</anticipatedstartdate>
    <actualstartdate>14/07/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate>11/03/2015</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize>21</actualsamplesize>
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Fertility North</primarysponsorname>
    <primarysponsoraddress>Suite 213, Specialist Medical Centre
Joondalup Health Campus
Shenton Ave
Joondalup WA 6027</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Fertility North</fundingname>
      <fundingaddress>Suite 213, Specialist Medical Centre
Joondalup Health Campus
Shenton Ave
Joondalup WA 6027</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Edith Cowan University</sponsorname>
      <sponsoraddress>270 Joondalup Drive,
Joondalup WA 6027</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Polyvinylpyrrolidone (PVP) has been routinely used in the intracytoplasmic sperm injection procedures to facilitate sperm handling for years although it's not degradable by the egg. Hyaluronan is a new alternative to PVP with all the features that PVP has and it's degradable by the egg. The proposed study aims at comparing the embryonic effect between these 2 reagents by using time-lapse analysis.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Joondalup Health Campus Human Research Ethics Committee</ethicname>
      <ethicaddress>Joondalup Health Campus,
Shenton Ave,
Joondalup, WA 6027</ethicaddress>
      <ethicapprovaldate>20/09/2013</ethicapprovaldate>
      <hrec>1319</hrec>
      <ethicsubmitdate>2/09/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Yanhe Liu</name>
      <address>Fertility North
Suite 213, Specialist Medical Centre,
Joondalup Health Campus,
Shenton Ave,
Joondalup WA 6027</address>
      <phone>+61 8 9301 1075</phone>
      <fax />
      <email>yanhe@fertilitynorth.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Phill Matson</name>
      <address>Fertility North
Suite 213, Specialist Medical Centre,
Joondalup Health Campus,
Shenton Ave,
Joondalup WA 6027</address>
      <phone>+61 8 9301 1075</phone>
      <fax />
      <email>phill.matson@fertilitynorth.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Phill Matson</name>
      <address>Fertility North
Suite 213, Specialist Medical Centre,
Joondalup Health Campus,
Shenton Ave,
Joondalup WA 6027</address>
      <phone>+61 8 9301 1075</phone>
      <fax />
      <email>phill.matson@fertilitynorth.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>